Dose finding study of high-dose epirubicin (E) and docetaxel (D) as first-line chemotherapy in advanced breast cancer (ABC)

被引：0
|
作者：
Pagani, O [1 ]
Sessa, C [1 ]
Martinelli, G [1 ]
Crivellari, D [1 ]
Goldhirsch, A [1 ]
机构：
[1] Int Breast Canc Study Grp, Bern, Switzerland
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP37
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] Dose-finding study of high-dose epirubicin (E) and docetaxel (D) as first-line chemotherapy in advanced breast cancer (ABC)
    Pagani, O
    Sessa, C
    Vandenbulcke, T
    Martinelli, G
    Zampino, G
    Nole, F
    Zimatore, M
    Locatelli, M
    Crivellari, D
    Buonadonna, A
    Thurlimann, B
    Hess, D
    Borner, M
    Bauer, J
    Riggi, M
    Riva, A
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1998, 9 : 16 - 16
  • [2] Dose finding study of high-dose epirubicin (E) and docetaxel (T) as first line chemotherapy in advanced breast cancer (ABC)
    Pagani, O
    Aapro, M
    Martinelli, G
    Bauer, J
    Borner, M
    Crivellari, D
    Thurlimann, B
    Vandenbulcke, T
    Goldhirsch, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 654 - 654
  • [3] High-dose epirubicin plus docetaxel at standard dose with lenograstim support as first-line therapy in advanced breast cancer
    Milla-Santos, A
    Rallo, L
    Solano, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (02): : 138 - 142
  • [4] Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer
    Venturini, M
    Del Mastro, L
    Garrone, O
    Angiolini, C
    Merlano, M
    Bergaglio, M
    Tolino, G
    Lambiase, A
    Baldini, A
    Canavese, G
    Rosso, R
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 546 - 552
  • [5] Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer
    S. H. Waters
    A. Gillibrand
    H. Berry
    S. Kumar
    G. Velikova
    D. J. Dodwell
    Timothy J. Perren
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 407 - 412
  • [6] Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer
    Waters, S. H.
    Gillibrand, A.
    Berry, H.
    Kumar, S.
    Velikova, G.
    Dodwell, D. J.
    Perren, Timothy J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 407 - 412
  • [7] Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer
    Pagani, O
    Sessa, C
    Martinelli, G
    Crivellari, D
    Buonadonna, A
    Thürlimann, B
    Hess, D
    Borner, M
    Bauer, J
    Zampino, G
    Zimatore, M
    Graffeo, R
    Riva, A
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1999, 10 (05) : 539 - 545
  • [8] Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer
    E. Espinosa
    S. Morales
    P. Borrega
    A. Casas
    C. Madroñal
    I. Machengs
    J. A. Illarramendi
    J. Lizón
    J. A. Moreno
    J. Belón
    J. Janáriz
    M. de la Puente
    T. Checa
    J. R. Mel
    M. González Barón
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 546 - 552
  • [9] Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer
    Espinosa, E
    Morales, S
    Borrega, P
    Casas, A
    Madroñal, C
    Machengs, I
    Illarramendi, J
    Lizón, J
    Moreno, J
    Belón, J
    Janáriz, J
    de la Puente, M
    Checa, T
    Mel, JR
    Barón, MG
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (06) : 546 - 552
  • [10] A phase I dose-finding study of capecitabine in combination with epirubicin and docetaxel as first-line chemotherapy in advanced breast cancer patients.
    Angiolini, C
    Venturini, M
    Del Mastre, L
    Bergaglio, M
    Garrone, O
    Merlano, M
    Tolino, G
    Lambiase, A
    Bighin, C
    Stevani, I
    Catzeddu, T
    Bertelli, G
    Rosso, R
    ANNALS OF ONCOLOGY, 2000, 11 : 36 - 36
12345